Cerebrovascular complications in patients with left-sided infective endocarditis: Out of site, out of mind

Clinical Infectious Diseases

Volumn 47, Issue 1, 2008, Pages 31-32

  Baddour, Larry M ^a,d   Bayer, Arnold S ^b,c  

^a Department of Health Sciences Research   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT;

BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HEART SURGERY; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STAPHYLOCOCCUS AUREUS; BRAIN EMBOLISM; ENDOCARDITIS; MORTALITY;

ENDOCARDITIS; HUMANS; INTRACRANIAL EMBOLISM;

EID: 46249134067     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588664     Document Type: Note

References (2)

1. Thuny F, Avierinos JF, Tribouilloy C, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 2007; 28:1155-61.
2. Snygg-Martin U, Gustafsson L, Rosengren L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008; 47:23-30 (in this issue).